Company Overview & Strategy - Enveric Biosciences focuses on developing FDA-approved therapeutic solutions using natural compounds to address side effects of cancer therapy, targeting unmet medical needs in supportive care [5] - The company's strategy involves identifying promising natural compounds, conducting rigorous scientific evaluation, and partnering for commercial opportunities [12, 13, 14, 15, 16] - Enveric Biosciences aims for a time- and cost-efficient path to commercialization through combination therapies and strategic investments [5] Financial Status & Key Accomplishments - As of March 2021, Enveric Biosciences has over $20 million in cash and no debt [19] - The company raised over $20 million in capital [19] - Enveric Biosciences started trading on Nasdaq in December 2020 [19] Pipeline & Partnerships - Enveric Biosciences is developing a pipeline of novel therapies for radiodermatitis, glioblastoma, and chemotherapy-induced neuropathy [25] - The company has an exclusive agreement with PureForm Global to support cannabinoid clinical programs [19, 36] - Enveric Biosciences acquired an exclusive license from Diverse Biotech for 5 molecules, primarily dermatology-focused [40] Market & Unmet Needs - Radiodermatitis affects approximately 95% of all cancer patients receiving radiation therapy [27] - Chemotherapy-induced neuropathy has a 68% incidence at 3 months [31] - Glioblastoma Multiforme (GBM) affects 22,000 adults in the US each year, with 15,000 resulting in death [35]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 95-4484725 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Title of Each Class Trading Symbol Name of Each Exchange on Which Registered Common Stock $0.01 par value per share AMRH The NASDAQ Stock Market LLC Warrants to Purchase Common Stock AMRHW The NASDAQ Stock Market LLC FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Commission file number 001-38286 AMERI Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 4080, McGinnis Ferry Road, Suite 1306, Alpharetta, Georgia (Address of principal executive offices) Registrant's tel ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Trading Symbol Name of Each Exchange on Which Registered Common Stock $0.01 par value per share AMRH The NASDAQ Stock Market LLC Warrants to Purchase Common Stock AMRHW The NASDAQ Stock Market LLC FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Commission file number 001-38286 AMERI Holdings, Inc. (Exact name of registrant ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Commission file number 001-38286 AMERI Holdings, Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------|-------------------------------------------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Trading Symbol Name of Each Exchange on Which Registered Common Stock $0.01 par value per share AMRH The NASDAQ Stock Market LLC Warrants to Purchase Common Stock AMRHW The NASDAQ Stock Market LLC FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Commission file number 001-38286 AMERI Holdings, Inc. (Exact name of regist ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Trading Symbol Name of Each Exchange on Which Registered Common Stock $0.01 par value per share AMRH The NASDAQ Stock Market LLC Warrants to Purchase Common Stock AMRHW The NASDAQ Stock Market LLC FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 Commission file number 001-38286 AMERI Holdings, Inc. (Exact name of registrant ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Trading Symbol Name of Each Exchange on Which Registered Common Stock $0.01 par value per share AMRH The NASDAQ Stock Market LLC Warrants to Purchase Common Stock AMRHW The NASDAQ Stock Market LLC FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 Commission file number 001-38286 AMERI Holdings, Inc. (Exact name of registrant ...

Part I [Item 1. Business](index=4&type=section&id=ITEM%201.%20BUSINESS) AMERI Holdings, Inc, provides SAP cloud, digital, and enterprise services globally with a strong US presence supported by offshore capabilities - The company's business model inverts the conventional global delivery model by having a strong U.S. presence supported by offshore capabilities in India and Canada[12](index=12&type=chunk) - Growth is driven by strategic acquisitions to expand service offerings in areas like SAP S/4 HANA, SAP Success Factors, and SAP Hybris[13](index=13&type=chunk)[23](index=23&type=chunk) - Service offerings are categorized into three main areas: Cloud Services, Digital Services (including mobile solutions and Robotic Process Automation), and Enterprise Services (including Business Intelligence and analytics)[25](index=25&type=chunk)[28](index=28&type=chunk)[30](index=30&type=chunk) - For the fiscal year 2018, the top five customers accounted for approximately **39% of total revenue**, indicating a significant client concentration[39](index=39&type=chunk) - As of December 31, 2018, the company had a total headcount of 390, which includes **188 billable subcontractors**[49](index=49&type=chunk) [Item 1A. Risk Factors](index=10&type=section&id=ITEM%201A.%20RISK%20FACTORS) The company faces substantial risks from a history of net losses, working capital constraints, intense competition, and potential Nasdaq delisting Historical Net Losses | Year | Net Revenue | Comprehensive Net Loss | | :--- | :--- | :--- | | 2018 | $43.0 million | $19.4 million | | 2017 | $48.6 million | $11.1 million | - The company faces working capital constraints and had outstanding cash payment obligations of approximately **$2.7 million** related to past acquisitions as of December 31, 2018[58](index=58&type=chunk) - On December 10, 2018, the company received a notice from Nasdaq for failing to meet the minimum **$1.00 per share bid price requirement**, posing a risk of delisting[160](index=160&type=chunk)[161](index=161&type=chunk) - A significant portion of revenue is concentrated in a limited number of clients, with the top five accounting for **39% of total revenue** in 2018[102](index=102&type=chunk)[103](index=103&type=chunk) - As of December 31, 2018, the company had approximately **$4 million in borrowings outstanding** under its senior secured credit facility[145](index=145&type=chunk) - Management concluded that as of December 31, 2018, the company's **internal control over financial reporting was not effective**, largely due to difficulties in integrating acquired private companies[195](index=195&type=chunk) [Item 1B. Unresolved Staff Comments](index=28&type=section&id=ITEM%201B.%20UNRESOLVED%20STAFF%20COMMENTS) The company reports no unresolved staff comments from the SEC - None[200](index=200&type=chunk) [Item 2. Properties](index=28&type=section&id=ITEM%202.%20PROPERTIES) The company's principal executive office is in Suwanee, Georgia, with additional leased offices in the US and India - The main executive office is in Suwanee, Georgia, with additional leased facilities in the U.S. and India totaling approximately **17,000 square feet**[200](index=200&type=chunk) [Item 3. Legal Proceedings](index=29&type=section&id=ITEM%203.%20LEGAL%20PROCEEDINGS) A lawsuit concerning unpaid earn-out payments from a subsidiary was settled in February 2019 for $200,000 - A lawsuit from a former member of Ameri Arizona regarding earn-out payments was **settled in February 2019 for $200,000**[202](index=202&type=chunk) [Item 4. Mine Safety Disclosures](index=29&type=section&id=ITEM%204.%20MINE%20SAFETY%20DISCLOSURES) This item is not applicable to the company - Not applicable[204](index=204&type=chunk) Part II [Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](index=30&type=section&id=ITEM%205.%20MARKET%20FOR%20REGISTRANT'S%20COMMON%20EQUITY%2C%20RELATED%20STOCKHOLDER%20MATTERS%20AND%20ISSUER%20PURCHASES%20OF%20EQUITY%20SECURITIES) The company's stock trades on Nasdaq, it has never paid dividends, and it issued unregistered stock for acquisition-related payments in 2018 - Common stock trades on The Nasdaq Capital Market under the ticker **"AMRH"**[206](index=206&type=chunk) - The company has a policy of retaining earnings for business development and has **never paid cash dividends** on its common stock[208](index=208&type=chunk) - Multiple unregistered stock issuances occurred in 2018 to satisfy earn-out and other payment obligations from the acquisitions of Virtuoso, Bigtech, and Ameri Arizona[209](index=209&type=chunk)[210](index=210&type=chunk)[211](index=211&type=chunk) [Item 6. Selected Financial Data](index=31&type=section&id=ITEM%206.%20SELECTED%20FINANCIAL%20DATA) This section is not applicable as the company qualifies as a smaller reporting company - Not applicable for smaller reporting companies[216](index=216&type=chunk) [Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=31&type=section&id=ITEM%207.%20MANAGEMENT'S%20DISCUSSION%20AND%20ANALYSIS%20OF%20FINANCIAL%20CONDITION%20AND%20RESULTS%20OF%20OPERATIONS) Fiscal 2018 revenue decreased 12% to $43.0 million and net loss widened to $19.5 million, driven by a $9.0 million goodwill impairment charge Results of Operations (Year Ended December 31) | Metric | 2018 | 2017 | | :--- | :--- | :--- | | Net Revenue | $42,998,280 | $48,593,712 | | Gross Profit | $8,983,504 | $10,237,745 | | Operating Loss | ($7,146,460) | ($10,896,531) | | Net Loss | ($16,897,516) | ($9,074,813) | | Net Loss Attributable to Common Stockholders | ($19,480,701) | ($11,163,964) | | Basic & Diluted Loss Per Share | ($0.82) | ($0.75) | - Revenue decreased by **$5.6 million (12%)** in 2018 compared to 2017, mainly because the company chose not to pursue certain low-margin professional services business[232](index=232&type=chunk) - The company recorded a **$9.0 million impairment charge** on goodwill and intangible assets in 2018, which was a primary driver of the increased net loss[238](index=238&type=chunk) - The company's financial condition raises **substantial doubt about its ability to continue as a going concern** due to recurring operational losses and negative working capital of $4.7 million as of December 31, 2018[261](index=261&type=chunk)[262](index=262&type=chunk) - In January 2019, the company entered into a new Loan and Security Agreement with North Mill Capital LLC, using an initial advance of **~$2.85 million** to repay its previous credit facility[265](index=265&type=chunk)[268](index=268&type=chunk) [Item 7A. Quantitative and Qualitative Disclosures About Market Risk](index=42&type=section&id=ITEM%207A.%20QUANTITATIVE%20AND%20QUALITATIVE%20DISCLOSURES%20ABOUT%20MARKET%20RISK) This section is not required as the company qualifies as a smaller reporting company - As a "smaller reporting company," this information is not required[298](index=298&type=chunk) [Item 8. Financial Statements and Supplementary Data](index=42&type=section&id=ITEM%208.%20FINANCIAL%20STATEMENTS%20AND%20SUPPLEMENTARY%20DATA) This item refers to the consolidated financial statements and supplementary data beginning on page F-1 of the report - The response to this Item is submitted as a separate section of this report beginning on page F-1[299](index=299&type=chunk) [Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](index=42&type=section&id=ITEM%209.%20CHANGES%20IN%20AND%20DISAGREEMENTS%20WITH%20ACCOUNTANTS%20ON%20ACCOUNTING%20AND%20FINANCIAL%20DISCLOSURE) The company reports no changes in or disagreements with its accountants on accounting and financial disclosure - None[299](index=299&type=chunk) [Item 9A. Controls and Procedures](index=42&type=section&id=ITEM%209A.%20CONTROLS%20AND%20PROCEDURES) Management concluded that both disclosure controls and internal control over financial reporting were not effective as of December 31, 2018 - Management concluded that **disclosure controls and procedures were not effective** as of December 31, 2018[302](index=302&type=chunk) - Management also concluded that **internal control over financial reporting was not effective** as of December 31, 2018[305](index=305&type=chunk) - The primary reason for the ineffectiveness is the difficulty in fully integrating acquired private companies and establishing consistent processes and procedures across all subsidiaries[302](index=302&type=chunk)[305](index=305&type=chunk) [Item 9B. Other Information](index=44&type=section&id=ITEM%209B.%20OTHER%20INFORMATION) The company received and addressed a Nasdaq non-compliance letter in March 2019 regarding independent director requirements for its committees - Received a Nasdaq non-compliance letter on March 21, 2019, regarding independent director requirements for board committees[309](index=309&type=chunk) - The company appointed Thoranath Sukumaran to the audit and compensation committees on March 25, 2019, to regain compliance[310](index=310&type=chunk) Part III [Item 10. Directors, Executive Officers and Corporate Governance](index=45&type=section&id=ITEM%2010.%20DIRECTORS%2C%20EXECUTIVE%20OFFICERS%20AND%20CORPORATE%20GOVERNANCE) Required information is incorporated by reference from the company's forthcoming definitive proxy statement - Information is incorporated by reference from the company's proxy statement[312](index=312&type=chunk) [Item 11. Executive Compensation](index=45&type=section&id=ITEM%2011.%20EXECUTIVE%20COMPENSATION) Required information is incorporated by reference from the company's forthcoming definitive proxy statement - Information is incorporated by reference from the company's proxy statement[314](index=314&type=chunk) [Item 12. Security Ownership of Certain Beneficial Owners, Management and Related Stockholder Matters](index=45&type=section&id=ITEM%2012.%20SECURITY%20OWNERSHIP%20OF%20CERTAIN%20BENEFICIAL%20OWNERS%2C%20MANAGEMENT%20AND%20RELATED%20STOCKHOLDER%20MATTERS) Required information is incorporated by reference from the company's forthcoming definitive proxy statement - Information is incorporated by reference from the company's proxy statement[315](index=315&type=chunk) [Item 13. Certain Relationships and Related Transactions and Director Independence](index=45&type=section&id=ITEM%2013.%20CERTAIN%20RELATIONSHIPS%20AND%20RELATED%20TRANSACTIONS%20AND%20DIRECTOR%20INDEPENDENCE) Required information is incorporated by reference from the company's forthcoming definitive proxy statement - Information is incorporated by reference from the company's proxy statement[316](index=316&type=chunk) [Item 14. Principal Accountants Fees and Services](index=45&type=section&id=ITEM%2014.%20PRINCIPAL%20ACCOUNTANTS%20FEES%20AND%20SERVICES) Required information is incorporated by reference from the company's forthcoming definitive proxy statement - Information is incorporated by reference from the company's proxy statement[317](index=317&type=chunk) Part IV [Item 15. Exhibits, Financial Statement Schedules](index=46&type=section&id=ITEM%2015.%20EXHIBITS%2C%20FINANCIAL%20STATEMENT%20SCHEDULES) This section lists all exhibits filed with the Form 10-K, including acquisition, financing, and corporate governance agreements - Lists various agreements including Share Purchase Agreements for acquisitions, Loan and Security Agreements, and forms of Warrants and Promissory Notes[319](index=319&type=chunk)[321](index=321&type=chunk) Financial Statements [Consolidated Financial Statements](index=51&type=section&id=Consolidated%20Financial%20Statements) The consolidated financial statements for 2018 and 2017 reveal a significant decline in financial health, with decreased assets, a widened net loss, and severe liquidity challenges Consolidated Balance Sheet Highlights (As of Dec 31) | Account | 2018 | 2017 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $1,371,331 | $4,882,084 | | Goodwill | $13,729,770 | $21,898,323 | | Total Assets | $29,637,450 | $52,196,628 | | **Liabilities & Equity** | | | | Total current liabilities | $14,688,965 | $30,367,882 | | Warrant liability | $4,189,388 | $0 | | Total Liabilities | $18,878,353 | $32,748,445 | | Total stockholders' equity | $10,759,097 | $19,448,183 | Consolidated Statement of Operations Highlights (Year Ended Dec 31) | Account | 2018 | 2017 | | :--- | :--- | :--- | | Net revenue | $42,998,280 | $48,593,712 | | Gross profit | $8,983,504 | $10,237,745 | | Impairment charges | $9,038,553 | $0 | | Net Income (loss) | ($16,897,516) | ($9,074,813) | Consolidated Cash Flow Highlights (Year Ended Dec 31) | Account | 2018 | 2017 | | :--- | :--- | :--- | | Net cash used in operating activities | ($2,565,495) | ($2,740,794) | | Net cash used in investing activities | ($3,639,246) | ($169,860) | | Net cash provided by financing activities | $2,693,988 | $6,412,851 | [Notes to Consolidated Financial Statements](index=56&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) The notes detail a $9.0 million impairment charge, warrant liability classification, debt defaults, and a full valuation allowance against deferred tax assets - The company recorded an impairment charge of **$8.2 million on goodwill** and **$0.9 million on certain customer lists** during 2018 due to declining future cash flow projections[419](index=419&type=chunk)[422](index=422&type=chunk) - In July/August 2018, the company completed a private placement that included warrants classified as a **derivative liability of $4.2 million** on the balance sheet[389](index=389&type=chunk)[339](index=339&type=chunk) - The company was **in default on its credit facility** with Sterling National Bank as of year-end 2018 and subsequently entered into a new loan agreement with North Mill Capital LLC[447](index=447&type=chunk)[473](index=473&type=chunk) - A **full valuation allowance of $6.1 million** was recorded against the company's deferred tax assets at December 31, 2018, as management concluded they were not more likely-than-not to be realizable[462](index=462&type=chunk) - Subsequent to year-end, in March 2019, the company received gross proceeds of approximately **$1.5 million from the exercise of warrants**[478](index=478&type=chunk)